These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17076642)

  • 21. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology.
    Chandler SG; Thomas NW; Illum L
    Pharm Res; 1994 Nov; 11(11):1623-30. PubMed ID: 7870681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents.
    Li Y; Wu X; Zhu Q; Chen Z; Lu Y; Qi J; Wu W
    Int J Pharm; 2019 Oct; 569():118584. PubMed ID: 31376466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.
    Mishima M; Okada S; Wakita Y; Nakano M
    J Pharmacobiodyn; 1989 Jan; 12(1):31-6. PubMed ID: 2656985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of insulin eyedrops.
    Pillion DJ; Atchison JA; Stott J; McCracken D; Gargiulo C; Meezan E
    J Ocul Pharmacol; 1994; 10(2):461-70. PubMed ID: 8083565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of systemic regular insulin via the ocular route in dogs.
    Morgan RV; Huntzicker MA
    J Ocul Pharmacol Ther; 1996; 12(4):515-26. PubMed ID: 8951688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory.
    Zhang X; Wang Y; Zheng C; Li C
    Eur J Pharm Biopharm; 2012 Sep; 82(1):76-84. PubMed ID: 22659236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
    Muramatsu K; Maitani Y; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1999 Oct; 25(10):1099-105. PubMed ID: 10529890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
    Dong Z; Katsumi H; Sakane T; Yamamoto A
    Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of aminated gelatin on the nasal absorption of insulin in rats.
    Seki T; Kanbayashi H; Nagao T; Chono S; Tomita M; Hayashi M; Tabata Y; Morimoto K
    Biol Pharm Bull; 2005 Mar; 28(3):510-4. PubMed ID: 15744079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.
    Uchida T; Toida Y; Sakakibara S; Miyanaga Y; Tanaka H; Nishikata M; Tazuya K; Yasuda N; Matsuyama K
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1261-6. PubMed ID: 11605651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cell-penetrating peptides on the nasal absorption of insulin.
    Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
    J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies to improve the intranasal absorption of insulin.
    Duan X; Mao S
    Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
    Najafabadi AR; Moslemi P; Tajerzadeh H
    Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocytes as oral delivery systems for human insulin.
    Al-Achi A; Greenwood R
    Drug Dev Ind Pharm; 1998 Jan; 24(1):67-72. PubMed ID: 15605599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of absorption of insulin-loaded polyisobutylcyanoacrylate nanospheres by sodium cholate after oral and subcutaneous administration in diabetic rats.
    Radwan MA
    Drug Dev Ind Pharm; 2001 Oct; 27(9):981-9. PubMed ID: 11763477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats.
    Eaimtrakarn S; Rama Prasad YV; Ohno T; Konishi T; Yoshikawa Y; Shibata N; Takada K
    J Drug Target; 2002 May; 10(3):255-60. PubMed ID: 12075827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.